top of page
Role of Ventripoint in meeting the COVID-19 challenge
VMS+ offers a key aid for diagnosis of patients presenting with suspected/confirmed COVID-19 and also in the ongoing management of care, a critical need with the current tsunami of heart disease related to COVID-19
Ventripoint's VMS+ is an ally in meeting the COVID challenge.
50% of people with COVID-19 have heart dysfunction, even if they have only mild-to-no symptoms. CNN's Covid Tracker estimates 400 million Covid cases worldwide as of Feb 14, 2022.
Current estimates are that 15% of COVID-19 patients will become Long-Haul patients.
bottom of page